Last Updated on February 28, 2021
As the frequency of diabetes diagnoses rise, there is an even more prevalent desire for the development of effective anti-diabetic drug treatment regimens to be developed. Diabetics are looking for better treatment options that will achieve a higher level of manageability over their disease.
The current prescription treatment options available on the market work well for some, but leave others plagued with undesirable side effects and a remaining difficulty in stopping complications associated with their disease.
Diabetics need more options, more variety, as there is no such thing as a one size fits all approach to diabetes management.
Fortunately, great strides have been in the works in the pharmaceutical industry for diabetic management. The current pharmaceutical market is limited when it comes to the variety of prescriptions that are offered as suitable treatments for diabetics, but as pharmaceutical companies push for the approval of new drugs for diabetes management, change is coming – and it is evident in the recent FDA approval of newly available prescription therapy options.
With the recent FDA approval of anti-diabetic drugs, sitagliptin and metformin hydrochloride, for market in the United States, diabetic patients may have access to new, more effective anti-diabetic treatment options. The newly available drugs are approved for specific combination regimens formulated especially for use in the treatment of type 2 diabetes – offered in a variation of dosages from 50mg/500mg and 50mg/1000mg respectively.
These kinds of drugs, formulated especially for the effective management of diabetes, works in a way that is specially designed to assist the body in its ability to metabolize glucose, successfully reducing the necessity for treatment with more aggressive diabetes management drugs like insulin.
This is great news for diabetics who currently find their treatment regimen to be ineffective or substandard to the level of management that their current treatment routine is achieving. More options, mean more opportunities for diabetics to achieve an overall higher quality of life – an accomplishment that is greatly appreciated amongst sufferers of chronic and often debilitating chronic illness.
The added bonus that comes with better treatment options and better overall health, is in the increase in eligibility for life insurance that diabetic patients can expect to anticipate when they achieve a more optimal level of health. The better managed a diabetic patient’s condition is, the better their chances are for purchasing premium life insurance policies that bring security and peace of mind.
As research continues to investigate the complexity of chronic illnesses and disease like diabetes, and as science evolves and matures, it’s safe to say that these achievements are only the beginning of the potential treatment possibilities that may be presented to diabetic patients in the near future.
Diabetes may not currently be a curable disease, but it is – now more than ever – a treatable disease.
As the pharmaceutical industry and the FDA continue to work closely towards a common goal to continue to release improved, more safe and more effective prescription drug options, diabetics can look forward to a more manageable condition so that they can spend less time plagued with nasty side-effects, stressing over blood glucose levels, and enduring diabetic complications, and more time enjoying a rewarding and exciting life.
In combination with a healthy diet and active lifestyle, diabetics can anticipate a better overall prognosis and an even more fulfilling life.